Osteoarthritis is a chronic degenerative joint disease characterized by a progressive deterioration of the cartilage, the tissue that covers the ends of the bones. As this cartilage thins and cracks, the joint loses its shock-absorbing capacity, leading to mechanical pain, stiffness, reduced mobility, and sometimes joint deformities. Contrary to a long-held belief, osteoarthritis does not result solely from age-related wear. Multiple factors contribute to the development of this disease. In addition to aging, excess body weight, repetitive mechanical stress, joint injuries, certain anatomical abnormalities, and genetic predispositions all play an important role.
From a pathophysiological perspective, osteoarthritis is accompanied by low-grade chronic inflammation and oxidative stress that is significant enough to disrupt the balance between cartilage synthesis and degradation.
The black seed oil is sometimes considered a natural remedy to alleviate joint pain associated with osteoarthritis, primarily due to its anti-inflammatory and antioxidant properties. These effects are largely attributed to thymoquinone, its main bioactive compound. Mechanistically, thymoquinone can inhibit the activation of pro-inflammatory signaling pathways such as NF-κB, leading to reduced production of inflammatory cytokines and mediators involved in pain and cartilage degradation. Furthermore, its antioxidant properties help limit the formation of free radicals, unstable molecules that accelerate cartilage breakdown.
By reducing both low-grade chronic inflammation and oxidative damage, Nigella sativa oil could be useful in osteoarthritis.
Several studies have relied on animal models to explore the effects of the Nigella sativa oil on joint inflammation and pain. One study thus focused on the preventive efficacy of black cumin oil in a polyarthritis model induced in rats by complete Freund’s adjuvant (CFA), an experimental model classically used to reproduce chronic joint inflammation. Nigella sativa oil was administered orally for 25 days at two different doses (0.91 and 1.82 mL/kg), compared to a group treated with indomethacin, a reference nonsteroidal anti-inflammatory drug. The results show that Nigella sativa oil significantly reduces joint edema, the arthritis score, and certain pain-related behavioral alterations. Biologically, a decrease in systemic inflammatory markers, notably interleukin-6 and C-reactive protein, was also observed.